{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:44:31Z","timestamp":1794717871279,"version":"4.9.1"},"reference-count":57,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,15]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>A high frequency of diverse activating mutations in costimulatory\/TCR-related signaling genes occurs in AITL and other TFH-derived PTCL. Deregulated TCR activation may play a role in the pathogenesis of TFH-derived PTCL, paving the way for developing novel targeted therapies.<\/jats:p>","DOI":"10.1182\/blood-2016-02-698977","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T21:00:05Z","timestamp":1467406805000},"page":"1490-1502","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":306,"title":["Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell\u2013derived lymphomas"],"prefix":"10.1182","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0703-6762","authenticated-orcid":false,"given":"David","family":"Vallois","sequence":"first","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pamela D.","family":"Dobay","sequence":"additional","affiliation":[{"name":"SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;"},{"name":"Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Lemonnier","sequence":"additional","affiliation":[{"name":"INSERM U955, Universit\u00e9 Paris-Est, D\u00e9partement de Pathologie, H\u00f4pital Henri-Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Missiaglia","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Juilland","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Iwaszkiewicz","sequence":"additional","affiliation":[{"name":"SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fataccioli","sequence":"additional","affiliation":[{"name":"INSERM U955, Universit\u00e9 Paris-Est, D\u00e9partement de Pathologie, H\u00f4pital Henri-Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Bisig","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Roberti","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasleen","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie et cytologie pathologiques, H\u00f4pital Necker, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Fabiani","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie et cytologie pathologiques, H\u00f4pital Saint-Antoine, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie pathologique, H\u00f4pital Avicenne, Bobigny, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Bonnet","sequence":"additional","affiliation":[{"name":"H\u00e9matologie clinique, CHU Li\u00e8ge, Li\u00e8ge, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Michielin","sequence":"additional","affiliation":[{"name":"SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland;"},{"name":"Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Jais","sequence":"additional","affiliation":[{"name":"Service de Biostatistiques, GH Necker-Enfants Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Figeac","sequence":"additional","affiliation":[{"name":"Plate-forme de G\u00e9nomique Fonctionnelle et Structurale, Institut Pour la Recherche sur le Cancer de Lille, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier A.","family":"Bernard","sequence":"additional","affiliation":[{"name":"INSERM U1170, Institut Gustave Roussy, Villejuif, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Delorenzi","sequence":"additional","affiliation":[{"name":"SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland;"},{"name":"Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"},{"name":"Ludwig Center for Cancer Research, University of Lausanne, Epalinges, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Haioun","sequence":"additional","affiliation":[{"name":"H\u00e9mopathies lymphoides, CHU Henri Mondor, Creteil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[{"name":"H\u00e9matologie Clinique, CHU Estaing, Clermont-Ferrand, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Thome","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, BC Cancer Agency, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"INSERM U955, Universit\u00e9 Paris-Est, D\u00e9partement de Pathologie, H\u00f4pital Henri-Mondor, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111902315007900_B1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.","volume":"31","author":"Federico","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111902315007900_B2","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"issue":"11","key":"2019111902315007900_B3","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111902315007900_B4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.seminhematol.2013.11.003","article-title":"Pathology of peripheral T-cell lymphomas: where do we stand?","volume":"51","author":"Gaulard","year":"2014","journal-title":"Semin Hematol"},{"issue":"S1","key":"2019111902315007900_B5","first-page":"100","article-title":"A PTCL, NOS subset with molecular and clinical features similar to AITL.","volume":"33","author":"Dobay","year":"2015","journal-title":"Hematol Oncol"},{"issue":"9","key":"2019111902315007900_B6","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"9","key":"2019111902315007900_B7","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/leu.2014.79","article-title":"Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.","volume":"28","author":"Corradini","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"2019111902315007900_B8","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111902315007900_B9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"26","key":"2019111902315007900_B10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes.","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111902315007900_B11","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1038\/bcj.2014.83","article-title":"Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.","volume":"4","author":"Muto","year":"2014","journal-title":"Blood Cancer J"},{"issue":"2","key":"2019111902315007900_B12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"2019111902315007900_B13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"2019111902315007900_B14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2019111902315007900_B15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.onc.1203259","article-title":"Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma.","volume":"19","author":"Cleverley","year":"2000","journal-title":"Oncogene"},{"issue":"9","key":"2019111902315007900_B16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111902315007900_B17","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"2019111902315007900_B18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12248","article-title":"Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.","volume":"263","author":"Inghirami","year":"2015","journal-title":"Immunol Rev"},{"issue":"5","key":"2019111902315007900_B19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.","volume":"207","author":"Pechloff","year":"2010","journal-title":"J Exp Med"},{"issue":"11","key":"2019111902315007900_B20","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma.","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"13","key":"2019111902315007900_B21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","article-title":"PLCG1 mutations in cutaneous T-cell lymphomas.","volume":"123","author":"Vaqu\u00e9","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111902315007900_B22","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2014.113696","article-title":"Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.","volume":"100","author":"Manso","year":"2015","journal-title":"Haematologica"},{"issue":"12","key":"2019111902315007900_B23","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome.","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"2019111902315007900_B24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes.","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"2019111902315007900_B25","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"issue":"7360","key":"2019111902315007900_B26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"5870","key":"2019111902315007900_B27","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"4","key":"2019111902315007900_B28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni.2540","article-title":"The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.","volume":"14","author":"Pelzer","year":"2013","journal-title":"Nat Immunol"},{"issue":"9","key":"2019111902315007900_B29","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ni824","article-title":"A requirement for CARMA1 in TCR-induced NF-kappa B activation.","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Immunol"},{"issue":"12","key":"2019111902315007900_B30","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.3324\/haematol.2015.133074","article-title":"A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.","volume":"100","author":"Lee","year":"2015","journal-title":"Haematologica"},{"issue":"5857","key":"2019111902315007900_B31","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1126\/science.1150799","article-title":"The structure of a human p110\u03b1\/p85\u03b1 complex elucidates the effects of oncogenic PI3Kalpha mutations.","volume":"318","author":"Huang","year":"2007","journal-title":"Science"},{"issue":"1","key":"2019111902315007900_B32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-4598-7-21","article-title":"Correlation between \u03b2-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.","volume":"7","author":"Austinat","year":"2008","journal-title":"Mol Cancer"},{"issue":"4","key":"2019111902315007900_B33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"2019111902315007900_B34","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1038\/srep08535","article-title":"Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.","volume":"5","author":"Stolze","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"2019111902315007900_B35","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.3324\/haematol.2013.101543","article-title":"STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression.","volume":"99","author":"Ohgami","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"2019111902315007900_B36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma.","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"issue":"20","key":"2019111902315007900_B37","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia.","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"15","key":"2019111902315007900_B38","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111902315007900_B39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma.","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"issue":"9","key":"2019111902315007900_B40","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111902315007900_B41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2013.271","article-title":"Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia.","volume":"28","author":"Bellanger","year":"2014","journal-title":"Leukemia"},{"issue":"11","key":"2019111902315007900_B42","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in \u03b3\u03b4 hepatosplenic T-cell lymphomas.","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"2019111902315007900_B43","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells.","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"issue":"26","key":"2019111902315007900_B44","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2014-05-573188","article-title":"Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization.","volume":"124","author":"Avbelj","year":"2014","journal-title":"Blood"},{"issue":"16","key":"2019111902315007900_B45","doi-asserted-by":"crossref","first-page":"9656","DOI":"10.1074\/jbc.273.16.9656","article-title":"Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue.","volume":"273","author":"Ihara","year":"1998","journal-title":"J Biol Chem"},{"issue":"35","key":"2019111902315007900_B46","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1038\/sj.onc.1203738","article-title":"The activation loop in Lck regulates oncogenic potential by inhibiting basal kinase activity and restricting substrate specificity.","volume":"19","author":"Laham","year":"2000","journal-title":"Oncogene"},{"issue":"24","key":"2019111902315007900_B47","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1158\/0008-5472.CAN-14-1420","article-title":"Phosphoinositide protein kinase PDPK1 is a crucial cell signaling mediator in multiple myeloma.","volume":"74","author":"Chinen","year":"2014","journal-title":"Cancer Res"},{"issue":"9","key":"2019111902315007900_B48","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/eji.200839031","article-title":"Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.","volume":"39","author":"Sacrist\u00e1n","year":"2009","journal-title":"Eur J Immunol"},{"issue":"8","key":"2019111902315007900_B49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.3016","article-title":"A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.","volume":"46","author":"Petrini","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"2019111902315007900_B50","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.18632\/oncotarget.2629","article-title":"Mutation of Vav1 adaptor region reveals a new oncogenic activation.","volume":"6","author":"Razanadrakoto","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"2019111902315007900_B51","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1084\/jem.20030913","article-title":"The strength of persistent antigenic stimulation modulates adaptive tolerance in peripheral CD4+ T cells.","volume":"198","author":"Singh","year":"2003","journal-title":"J Exp Med"},{"issue":"5","key":"2019111902315007900_B52","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/blood-2015-12-683458","article-title":"Opposite RHOA functions within the ATLL category.","volume":"127","author":"Ishikawa","year":"2016","journal-title":"Blood"},{"key":"2019111902315007900_B53","doi-asserted-by":"crossref","first-page":"8470","DOI":"10.1038\/ncomms9470","article-title":"Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in S\u00e9zary syndrome.","volume":"6","author":"Kiel","year":"2015","journal-title":"Nat Commun"},{"issue":"15","key":"2019111902315007900_B54","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2019111902315007900_B55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s12185-015-1738-8","article-title":"Multistep tumorigenesis in peripheral T cell lymphoma.","volume":"102","author":"Sakata-Yanagimoto","year":"2015","journal-title":"Int J Hematol"},{"issue":"1","key":"2019111902315007900_B56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111902315007900_B57","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjh.13170","article-title":"Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.","volume":"168","author":"Cheminant","year":"2015","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/11\/1490\/1395491\/1490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/11\/1490\/1395491\/1490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:34:48Z","timestamp":1574130888000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/11\/1490\/35240\/Activating-mutations-in-genes-related-to-TCR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-02-698977","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}